Skip to main content
. 2022 May 26;1(2):100029. doi: 10.1016/j.jacadv.2022.100029

Table 3.

Accumulated Total Costs Excluding Subjects Who Died or Underwent Heart Transplantation

MBTTS RVPAS P Value
Total costs
 1 y, n = 107 (72%), 114 (74%) $656,004 ± 331,984 $776,547 ± 556,160 0.05
 3 y, n = 95 (64%), 95 (62%) $875,549 ± 623,776 $972,656 ± 926,326 0.40
 5 y, n = 56 (38%), 66 (43%) $1,209,790 ± 1,092,009 $1,290,784 ± 1,241,318 0.71
Total daily costs
 1 y, n = 107 (72%), 114 (74%) $1,796 ± 909 $2,126 ± 1,523 0.05
 3 y, n = 95 (64%), 95 (62%) $799 ± 569 888 ± 845 0.40
 5 y, n = 56 (38%), 66 (43%) $662 ± 598 707 ± 680 0.71

Values are mean ± SD in US$.

For each time period, the number of participants and the percentage of the total cohort are listed.

MBTTS = modified Blalock-Taussig-Thomas shunts; RVPAS = right ventricle to pulmonary artery shunts.